Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Ruxolitinib cream may help treat severe hair loss in children.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Upadacitinib may effectively treat resistant lichen planopilaris.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Ritlecitinib can help about 14,000 people with severe hair loss.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Jujube seeds have many health benefits and could be a valuable natural remedy.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.